Company Filing History:
3 out of 1,997 
1 out of 517 
Years Active: 2006-2015
Title: Thomas Suchyna: Innovator in Biomedical Engineering
Introduction
Thomas Suchyna is a notable inventor based in Amherst, NY (US), recognized for his contributions to biomedical engineering. He holds 3 patents that focus on innovative methods and compositions aimed at addressing critical health issues, particularly in the realm of sickle cell anemia and cardiac arrhythmias.
Latest Patents
Among his latest patents, one invention provides methods and compositions for inhibiting calcium permeable cation conductance of red blood cells from individuals afflicted with sickle cell anemia. This method involves exposing the cells to the peptide GsMTx4 and/or its variants. Another significant patent discloses a peptide of SEQ ID NO:1 and its variants that block stretch-activated ion channels. This peptide, designated as D-GsMTx4, is an enantiomer of a peptide found in the venom of a spider. The invention also includes a method for inhibiting stretch-activated ion channels in a cell, which can be utilized for treating cardiac arrhythmias and other pathologies involving mechanical stress alterations.
Career Highlights
Throughout his career, Thomas Suchyna has worked with esteemed institutions such as the State University of New York and Beth Israel Deaconess Medical Center, Inc. His work has significantly impacted the field of biomedical research, particularly in developing therapeutic strategies for complex medical conditions.
Collaborations
Thomas has collaborated with notable colleagues, including Frederick Sachs and Janice Johnson, contributing to a rich exchange of ideas and advancements in their respective fields.
Conclusion
Thomas Suchyna's innovative work and patents reflect his dedication to improving health outcomes through scientific research and invention. His contributions continue to influence the biomedical engineering landscape, showcasing the importance of innovation in addressing critical health challenges.